{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:36:45Z","timestamp":1760189805889},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1990,10,1]],"date-time":"1990-10-01T00:00:00Z","timestamp":654739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1990,10,1]],"date-time":"1990-10-01T00:00:00Z","timestamp":654739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Ricerca in Clin. Lab."],"published-print":{"date-parts":[[1990,10]]},"DOI":"10.1007\/bf02900707","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T13:14:38Z","timestamp":1639487678000},"source":"Crossref","is-referenced-by-count":11,"title":["High-purity factor VIII concentrates produced without using monoclonal antibodies"],"prefix":"10.1007","volume":"20","author":[{"given":"Pier Mannuccio","family":"Mannucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Gringeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02900707_CR1","unstructured":"Blomb\u00e4ck M., Cinotti S., Longo G., Messori A., Morfini M., Schimpf K.: Pharmacokinetics of two pasteurized factor VIII concentrates: a multicenter study on the reproducibility of parameters using different assay methods. In: 19th International Congress of the World Federation of Hemophilia, Washington DC, August 14\u201319, 1990. (Abstract no 103)."},{"key":"BF02900707_CR2","first-page":"81","volume":"62","author":"D. B. Brettler","year":"1989","unstructured":"Brettler D. B.: Proposed protocol for the evaluation of the effect of high purity factor concentrates on immune system of hemophilia patients \u2014 Thrombos. Haemostas.62, 81, 1989.","journal-title":"Thrombos. Haemostas."},{"key":"BF02900707_CR3","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood.V73.7.1859.1859","volume":"73","author":"D. B. Brettler","year":"1989","unstructured":"Brettler D. B., Forsberg A. D., Levine P. H., Petillo J., Lamon K., Sullivan J. L.: Factor VIII:C concentrate purified from plasma using monoclonal antibodies: human studies \u2014 Blood73, 1859, 1989.","journal-title":"Blood"},{"key":"BF02900707_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ajh.2830310108","volume":"31","author":"W. A. Fricke","year":"1989","unstructured":"Fricke W. A., Mei-Ying Wong Yu: Characterization of von Willebrand factor in factor VIII concentrates \u2014 Amer. J. Hematol.31, 41, 1989.","journal-title":"Amer. J. Hematol."},{"key":"BF02900707_CR5","unstructured":"Gazangel C., Tarchet M. F., and the French Hemophilia Study Group: Viral safety of solvent\/detergent treated FVIII concentrate. Results of a French Multicenter Study. In: 18th International Congress of the World Federation of Hemophilia, Madrid, May 26\u201331, 1988. (Abstract book, p. 124)."},{"key":"BF02900707_CR6","unstructured":"Gomperts E., Addiego J., Gill J.: What is the impact of monoclonal Ab purified, plasmaderived FVIII on immune function in hemophilia A patients? \u2014 Blood75 (Suppl. 1), 39a, 1989. (Abstract)."},{"key":"BF02900707_CR7","first-page":"307","volume":"58","author":"M. Griffith","year":"1987","unstructured":"Griffith M., Liu S., Neslund G., Tsang I., Lettelier D., Berkebile R.: Preparation of high specific activity plasma AHF by anti-FVIII:C immunoaffinity chromatography \u2014 Thrombos. Haemostas.58, 307, 1987. (Abstract).","journal-title":"Thrombos. Haemostas."},{"key":"BF02900707_CR8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1537-2995.1985.25686071422.x","volume":"25","author":"B. Horowitz","year":"1985","unstructured":"Horowitz B., Wiebe M. E., Lippin A., Stryker M. H.: Inactivation of viruses in labile blood derivatives. I. Disruption of lipid enveloped viruses by tri-(n-butyl)-phosphate detergent combinations \u2014 Transfusion (Philad.)25, 516, 1985.","journal-title":"Transfusion (Philad.)"},{"key":"BF02900707_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0140-6736(88)92288-X","volume":"ii","author":"M. S. Horowitz","year":"1988","unstructured":"Horowitz M. S., Rooks C., Horowitz B., Hilgartner M.: Virus safety of solvent\/detergent treated antihemophilic factor concentrate \u2014 Lancetii, 186, 1988.","journal-title":"Lancet"},{"key":"BF02900707_CR10","unstructured":"Kosow D. P., Bhattacharya P., Goldsmith J. C., Heldebrant C. M., Kasper C. K., Novak P., Sternberg C., Tondreau S. C.: Affinity chromatography purification of factor VIII. In: 19th International Congress of the World Federation of Hemophilia, Washington DC, August 14\u201319, 1990. (Abstract no 98)."},{"key":"BF02900707_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1365-2141.1989.tb00227.x","volume":"73","author":"A. S. Lawrie","year":"1989","unstructured":"Lawrie A. S., Harrison P., Armstrong A. L., Wilbourn B. R., Dalton R. G., Savidge G. F.: Comparison of thein vitro characteristics of von Willebrand factor in British and commercial factor VIII concentrates \u2014 Brit. J. Haematol.73, 100, 1989.","journal-title":"Brit. J. Haematol."},{"key":"BF02900707_CR12","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/bmj.293.6553.978","volume":"293","author":"R. Madhok","year":"1986","unstructured":"Madhok R., Gracie A., Lowe G. D. O., Burnett A., Froebel K., Follet E., Forbes C. D.: Impaired cell-mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus \u2014 Brit. med. J.293, 978, 1986.","journal-title":"Brit. med. J."},{"key":"BF02900707_CR13","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S0140-6736(88)92426-9","volume":"ii","author":"P. M. Mannucci","year":"1988","unstructured":"Mannucci P. M., Colombo M.: Virucidal treatment of clotting factor concentrates \u2014 Lancetii, 782, 1988.","journal-title":"Lancet"},{"key":"BF02900707_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajh.2830250106","volume":"25","author":"P. M. Mannucci","year":"1987","unstructured":"Mannucci P. M., Moia M., Rebulla P., Altieri D., Monteagudo J., Castillo R.: Correction of the bleeding time in treated patients with severe von Willebrand disease is not solely dependent on the normal multimeric structure of plasma von Willebrand factor \u2014 Amer. J. Hematol.25, 55, 1987.","journal-title":"Amer. J. Hematol."},{"key":"BF02900707_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-113-1-27","volume":"113","author":"P. M. Mannucci","year":"1990","unstructured":"Mannucci P. M., Schimpf K., Brettler D. B., Ciavarella N., Colombo M., Haschke F., Lechner K., Lusher J. M., Weissbach G., and the International Study Group: Low risk of hepatitis C after a high-purity, pasteurized factor VIII concentrate \u2014 Ann. intern. Med.113, 27, 1990.","journal-title":"Ann. intern. Med."},{"key":"BF02900707_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0049-3848(89)90159-X","volume":"56","author":"M. Morfini","year":"1989","unstructured":"Morfini M., Rafanelli D., Filimberti E., Cinotti S., Piazza E., Longo G., Rossi Ferrini P.: Protein content and factor VIII complex in untreated, treated and monoclonal factor VIII concentrates \u2014 Thrombos. Res.56, 169, 1989.","journal-title":"Thrombos. Res."},{"key":"BF02900707_CR17","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/S0140-6736(89)90679-X","volume":"ii","author":"L. Noel","year":"1989","unstructured":"Noel L., Guerois C., Maisonneuve P., Verroust F., Laurian Y.: Antibodies to hepatitis C virus in hemophilia \u2014 Lancetii, 560, 1989.","journal-title":"Lancet"},{"key":"BF02900707_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S0140-6736(86)91101-3","volume":"i","author":"A. M. Prince","year":"1986","unstructured":"Prince A. M., Horowitz B., Brotman B.: Sterilization of hepatitis and HTLV-III viruses by exposure to tri-(n-butyl)-phosphate and sodium cholate \u2014 Lanceti, 706, 1986.","journal-title":"Lancet"},{"key":"BF02900707_CR19","volume-title":"Recent Advances in Hemophilia Care","author":"R. H. Rousell","year":"1990","unstructured":"Rousell R. H., Abildgaard C. F., Brockway W. J., Dobkin M. B., Harrison J., Hein R., Pappanhagen A. R., Sanchez L. H.: Koate-HP: a new plasma-derived factor VIII concentrate. In:Kasper C. K. (Ed.): Recent Advances in Hemophilia Care. Alan R. Liss, New York, 1990. (Abstract no 307)."},{"key":"BF02900707_CR20","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198910263211702","volume":"321","author":"K. Schimpf","year":"1989","unstructured":"Schimpf K., Brackmann H. H., Kreuz W., Kraus B., Haschke F., Schramm W., Moesseler J., Auerswald G., Sutor A. H., Koehler K., Hellstern P., Muntean W., Scharrer I.: Absence of antihuman immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand\u2019s disease with pasteurized factor VIII concentrate \u2014 New Engl. J. Med.321, 1148, 1989.","journal-title":"New Engl. J. Med."},{"key":"BF02900707_CR21","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJM198704093161505","volume":"316","author":"K. Schimpf","year":"1987","unstructured":"Schimpf K., Mannucci P. M., Kreuz W., Brackmann H. H., Auerswald G., Ciavarella N., Moesseler J., DeRosa V., Kraus B., Breukmann C., Mancuso G., Mittler U., Haschke F., Morfini M.: Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia A and no previous transfusion \u2014 New Engl. J. Med.316, 918, 1987.","journal-title":"New Engl. J. Med."},{"key":"BF02900707_CR22","first-page":"231","volume":"16","author":"K. Schimpf","year":"1986","unstructured":"Schimpf K., Reis B.: Comparison of recovery and half-life of a new factor VIII high-purity concentrate (FVIII C HS) with a factor VIII HS (Hemate P) \u2014 La Ricerca Clin. Lab.16, 231, 1986. (Abstract).","journal-title":"La Ricerca Clin. Lab."},{"key":"BF02900707_CR23","first-page":"27","volume":"25","author":"A. B. Schreiber","year":"1988","unstructured":"Schreiber A. B.: The pre-clinical characterization of Monoclate factor VIII:C antihemophilic factor (human) \u2014 Semin. Hematol.25, 27, 1988.","journal-title":"Semin. Hematol."},{"key":"BF02900707_CR24","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0022-3476(86)80823-X","volume":"108","author":"J. L. Sullivan","year":"1986","unstructured":"Sullivan J. L., Brewster F. E., Brettler D. B., Forsberg A. D., Cheeseman S. H., Byron K. S., Baker S. M., Willets D. L., Lew R. A., Levine P. H.: Hemophilic immunodeficiency: influence of exposure to factor VIII concentrate. LAV\/HTLV-III and herpes viruses \u2014 J. Pediatr.108, 504, 1986.","journal-title":"J. Pediatr."}],"container-title":["La Ricerca in Clinica e in Laboratorio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02900707.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02900707\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02900707.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T13:15:00Z","timestamp":1639487700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02900707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,10]]}},"alternative-id":["BF02900707"],"URL":"https:\/\/doi.org\/10.1007\/bf02900707","relation":{},"ISSN":["0390-5748"],"issn-type":[{"value":"0390-5748","type":"print"}],"subject":[],"published":{"date-parts":[[1990,10]]},"article-number":"227"}}